Lv639
1790 积分 2024-04-07 加入
A phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab in patients with advanced solid tumors
30分钟前
已完结
The LEAP Program: Lenvatinib Plus Pembrolizumab for the Treatment of Advanced Solid Tumors
2天前
已完结
Antibody-bottlebrush prodrug conjugates for targeted cancer therapy
4天前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
14天前
已完结
The role of synthetic lethality in overcoming cancer therapy resistance: emerging paradigm and recent advances
14天前
已完结
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates
16天前
已完结
Evolution of claudin18.2 therapies in gastroesophageal cancers
23天前
已完结
KRAS: the Achilles’ heel of pancreas cancer biology
27天前
已完结
Regulatory T cells in the tumour microenvironment
28天前
已完结
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
28天前
已完结
皖公网安备34019202002308
